118 related articles for article (PubMed ID: 19960482)
1. Cognitive impairment and the role of the ApoE epsilon4-allele after stroke--a 13 months follow-up study.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Int J Geriatr Psychiatry; 2010 Aug; 25(8):833-42. PubMed ID: 19960482
[TBL] [Abstract][Full Text] [Related]
2. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
3. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
4. Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline.
Sachs-Ericsson N; Corsentino E; Collins N; Sawyer K; Blazer DG
Aging Ment Health; 2010 Mar; 14(2):138-44. PubMed ID: 19946803
[TBL] [Abstract][Full Text] [Related]
5. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
[TBL] [Abstract][Full Text] [Related]
6. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.
Louko AM; Vilkki J; Niskakangas T
Acta Neurol Scand; 2006 Nov; 114(5):315-9. PubMed ID: 17022778
[TBL] [Abstract][Full Text] [Related]
7. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
8. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
9. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
10. Mortality in amnestic mild cognitive impairment: a prospective community study.
Hunderfund AL; Roberts RO; Slusser TC; Leibson CL; Geda YE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2006 Nov; 67(10):1764-8. PubMed ID: 17130407
[TBL] [Abstract][Full Text] [Related]
11. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
12. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
Silbert BS; Evered LA; Scott DA; Cowie TF
Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
[TBL] [Abstract][Full Text] [Related]
13. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
[TBL] [Abstract][Full Text] [Related]
14. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
16. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
[TBL] [Abstract][Full Text] [Related]
17. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
18. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
19. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J; Fisk JD
Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
